Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Condition: Diabetes Mellitus, Type 2Intervention: Drug: rosiglitazone maleate/metformin hydrochlorideSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified June 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2007 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Condition: Diabetes Mellitus, Type 2Intervention: Drug: rosiglitazone maleate/metformin hydrochlorideSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2007 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Condition: Diabetes Mellitus, Type 2Intervention: Drug: rosiglitazone maleate/metformin hydrochlorideSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified June 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2007 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Condition: Diabetes Mellitus, Type 2Intervention: Drug: rosiglitazone maleate/metformin hydrochlorideSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2007 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Condition: Diabetes Mellitus, Type 2Intervention: Drug: rosiglitazone maleate/metformin hydrochlorideSponsor: GlaxoSmithKlineCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2007 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Condition: Diabetes Mellitus, Type 2Intervention: Drug: rosiglitazone maleate/metformin hydrochlorideSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2007 Category: Research Source Type: clinical trials
Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
Conditions: Diabetes; Diabetes Mellitus, Type 2Interventions: Drug: repaglinide and metformin combination tablet; Drug: rosiglitazone and metformin combination tabletSponsor: Novo Nordisk A/SCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2006 Category: Research Source Type: clinical trials
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
Condition: Diabetes Mellitus, Type 2Interventions: Drug: Rosiglitazone; Drug: Sulfonylurea; Drug: MetforminSponsor: GlaxoSmithKlineCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2006 Category: Research Source Type: clinical trials
Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
Condition: Type 2 Diabetes MellitusInterventions: Drug: sitagliptin; Drug: Comparator: Placebo; Drug: rosiglitazone; Drug: metformin; Drug: glipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2006 Category: Research Source Type: clinical trials
